Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision

Recruiting now

Conditions studied: Quality of Life, Stigmatization

In brief

Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was feared. Recent data proof that the risk for malignancy was overestimated. Nowadays still a lot of patients express their wish for surgical removal out of aesthetic reasons and psychological impacts. Many patients and families experience stigmatization because of the nevus. To proof a medical indication for surgical removal the investigators want to evaluate the quality of life and stigmatization before and after nevus surgery.

Key facts

Study ID

NCT02280889

Run by

University Children's Hospital, Zurich

People needed

100

Starts

2013-05-01

Expected to finish

2031-12-01

Last updated by the study team

2026-03-04

Who can join

Age: 1 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with a congenital melanocytic nevi of at least 2 cm2 that will be removed surgically
• age between 9 months and 16 years

You may not qualify if…

• mental retardation of the child
• insufficient knowledge of the German language of both parents
• severe comorbidities
• previous therapies done for the CMN (dermabrasion, surgery, laser)

Where it is running

• University Children's Hospital Zurich, Division of Pediatric Plastic and reconstructive Surgery — Zurich, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.